York Pei

16.7k citations

147 papers · 10.0k indexed · 4 hit papers · h-index 54

Impact in

Nephrology top 0.1%
- Renal Diseases and Glomerulopathies
- Parathyroid Disorders and Treatments
Genetics top 0.1%
- Genetic and Kidney Cyst Diseases
- Genetic Syndromes and Imprinting

Papers in

Nephrology 40
- Renal Diseases and Glomerulopathies 25
- Parathyroid Disorders and Treatments 9
Genetics 96
- Genetic and Kidney Cyst Diseases 92
- Genetic Syndromes and Imprinting 36

Co-authors: Celia M.T. Greenwood Xuewen Song Gavril Hercz Andrew D. Paterson Donald J. Sherrard Terry Watnick Gino V. Segre Carl Saiphoo
Journals: Kidney International (16 papers)Journal of the American Society of Nephrology (14 papers)Clinical Journal of the American Society of Nephrology (10 papers)American Journal of Kidney Diseases (9 papers)Canadian Journal of Kidney Health and Disease (6 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

York Pei

142 papers receiving 9.8k citations

Hit Papers

align trajectories log scale

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2015 · 384 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Kidney International
2013 Nature Medicine
2002 Nature
1993 Kidney International

Peers

Countries citing papers authored by York Pei

Since Specialization

Citations

This map shows the geographic impact of York Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by York Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites York Pei more than expected).

Fields of papers citing papers by York Pei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by York Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by York Pei. The network helps show where York Pei may publish in the future.

Co-authorship network

The 25 scholars most cited alongside York Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with York Pei Line = papers co-authored together York Pei links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Autosomal dominant polycystic kidney disease The Lancet ·(unknown), 敏朗小柳, Qiusheng Yang, 浜田良樹, York Pei	2026	0
2	Association of Kidney Volume With Patient-Reported Outcomes in ADPKD Kidney International Reports ·Franja Božnar, Matthew Ho, A. M. L. Pereira, Yuan Su, Maren Cam, Wei Luo, Irvi Yuliana, Renata Gabriela Pereira Cunha Pontes, Pierre Antoine Brown, Stephen Tyrrell, Archana Paswan, Anusha Nadig, Korosh Khalili, アリセ喜納, York Pei	2026	1
3	Navigating the Global Economic Landscape of Dialysis: A Summary of Expert Opinions from The 4th International Congress of Chinese Nephrologists SHILAP Revista de lepidopterología ·Philip Kam‐Tao Li, Jack Kit‐Chung Ng, Guangyan Cai, Wei Chen, Kai Ming Chow, Stanley Fan, Nassima Belhadj, Lai Seong Hooi, York Pei, Boon Wee Teo, Muh Geot Wong, I‐Wen Wu, Jianhui Zhou, Noorjannah Noorjannah, Zhiming Ye, Xueqing Yu	2024	1
4	Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial American Journal of Kidney Diseases ·Ronald T. Gansevoort, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B. Chapman, Shigeo Horie, Bertrand Knebelmann, Michal Mrug, Albert Ong, York Pei, Vicente E. Torres, Vijay Modur, Yassin Dia, Ronald D. Perrone	2022	12
5	Tackling Dialysis Burden around the World: A Global Challenge SHILAP Revista de lepidopterología ·Philip Kam‐Tao Li, Gordon Chun‐Kau Chan, Jianghua Chen, Hung‐Chun Chen, Yuk‐Lun Cheng, Stanley Fan, John Cijiang He, Weixin Hu, Girma Demeke, York Pei, Boon Wee Teo, Ping Zhang, Xueqing Yu, Zhihong Liu	2021	28
6	LAMA2 and LOXL4 are candidate FSGS genes BMC Nephrology ·裕至栗山, Christopher Daudish, Tony Yao, MARIO DE LUCA, Andrew D. Paterson, Rohan John, Bernard Davenport, Rachel Lennon, York Pei, Moumita Barua	2021	2
7	Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing Journal of the American Society of Nephrology ·Matthew B. Lanktree, Amirreza Haghighi, Elsa Guiard, 沈高, Xuewen Song, Peter C. Harris, Andrew D. Paterson, York Pei	2018	181
8	Isolated polycystic liver disease genes define effectors of polycystin-1 function Journal of Clinical Investigation ·Whitney Besse, Ke Dong, Jungmin Choi, Sohan Punia, Sorin V. Fedeles, Murim Choi, Anna‐Rachel Gallagher, Emily Huang, Ashima Gulati, James Knight, Shrikant Mane, Esa Tahvanainen, Pia Tahvanainen, Simone Sanna‐Cherchi, Richard P. Lifton, Terry Watnick, York Pei, Vicente E. Torres, Stefan Somlo	2017	123
9	Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring Clinical Proteomics ·Ana Konvalinka, Ihor Batruch, Tomáš Tokár, Apostolos Dimitromanolakis, 久仁夫鈴木, Xuewen Song, York Pei, Andrei P. Drabovich, Eleftherios P. Diamandis, Igor Jurišica, James W. Scholey	2016	20
10	Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4 cm Can Be Offered Active Surveillance as an Initial Management Strategy European Urology ·Jaimin R. Bhatt, Patrick O. Richard, M Cotter, Antonio Finelli, Y. KARAGUL YUCEER, Laura Legere, Andrew Evans, York Pei, Jenna Sykes, Kartik Jhaveri, Michael A.S. Jewett	2016	89
11	Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease Journal of the American Society of Nephrology ·Young‐Hwan Hwang, John Conklin, Winnie Chan, Nicole M. Roslin, Jannel Liu, Ning He, Kairong Wang, Jamie L. Sundsbak, Christina M. Heyer, Masoom A. Haider, Andrew D. Paterson, Peter C. Harris, York Pei	2015	113
12	Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML) Urology ·Anil Kapoor, Louis Girard, Jean‐Baptiste Lattouf, York Pei, Ricardo Rendon, Abdelkader El Kebir, Alan So	2015	18
13	Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases Clinical Journal of the American Society of Nephrology ·Vicente E. Torres, Alessandra Boletta, Arlene B. Chapman, Vincent H. Gattone, York Pei, Qi Qian, Darren P. Wallace, Thomas Weimbs, Rudolf P. Wüthrich	2010	74
14	Polycystin-1 C-terminal tail associates with β-catenin and inhibits canonical Wnt signaling Human Molecular Genetics ·Mark Lal, Xuewen Song, Jennifer L. Pluznick, Valeria Di Giovanni, David Merrick, Norman D. Rosenblum, Véronique Chauvet, Cara J. Gottardi, York Pei, Michael J. Caplan	2008	142
15	Analysis of PKD1 for genomic deletion by multiplex ligation-dependent probe assay: Absence of hot spots Genomics ·Piotr Kozłowski, John J. Bissler, York Pei, David J. Kwiatkowski	2007	20
16	Diagnostic Approach in Autosomal Dominant Polycystic Kidney Disease Clinical Journal of the American Society of Nephrology ·York Pei	2006	62
17	Angiotensin-converting enzyme 2 is an essential regulator of heart function Nature ·Michael A. Crackower, Renu Sarao, Gavin Y. Oudit, Chana Yagil, I. Kozieradzki, Sam Scanga, Antonio J. Oliveira-dos-Santos, Shaimaa S.A.O. Fagir, Liyong Zhang, York Pei, James W. Scholey, Carlos M. Ferrario, Armen S. Manoukian, Mark C. Chappell, Peter H. Backx, Yoram Yagil, Josef Penninger Hit paper breakdown →	2002	1340
18	Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations Nature Genetics ·Terry Watnick, 朋子塩屋, Kairong Wang, Yan Liang, Patrick S. Parfrey, Donna Hefferton, Peter St George‐Hyslop, Gregory G. Germino, York Pei	2000	102
19	LINE-1 Elements at the Sites of Molecular Rearrangements in Alport Syndrome–Diffuse Leiomyomatosis The American Journal of Human Genetics ·Yoav Segal, Bernard Peissel, Alessandra Renieri, Mario Marchi, Andrea Ballabio, York Pei, Jing Zhou	1999	80
20	The spectrum of bone disease in end-stage renal failure—An evolving disorder Kidney International ·Donald J. Sherrard, Gavril Hercz, York Pei, Norma A. Maloney, Celia M.T. Greenwood, Arif Manuel, Carl Saiphoo, Stanley S.A. Fenton, Gino V. Segre Hit paper breakdown →	1993	550

About York Pei

York Pei is a scholar working on Nephrology, Genetics, Transplantation, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 147 papers that have together received 10.0k indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (92 papers), Renal and related cancers (66 papers), Genetic Syndromes and Imprinting (36 papers), Renal Diseases and Glomerulopathies (25 papers), Renal cell carcinoma treatment (14 papers), Pediatric Urology and Nephrology Studies (13 papers), Biomedical Research and Pathophysiology (11 papers) and Parathyroid Disorders and Treatments (9 papers). The work is most often cited by research in Nephrology (2.8k citations), Genetics (4.8k citations), Pathology and Forensic Medicine (1.6k citations), Transplantation (230 citations) and Molecular Biology (4.7k citations). York Pei has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Celia M.T. Greenwood, Xuewen Song, Gavril Hercz, Andrew D. Paterson, Donald J. Sherrard, Terry Watnick, Gino V. Segre, Carl Saiphoo, Arif Manuel and Patrick S. Parfrey. Their work appears in journals such as Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases and Canadian Journal of Kidney Health and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact